https://www.icta.fr/case-studies/pain-relief-and-protection-of-three-self-treated-dermatological-foot-conditions/ 2026-01-14T10:03:09+00:00 https://www.icta.fr/fr/cas-clients/a-first-in-human-trial-of-monoclonal-antibody-imp-in-patients-with-anti-mullerian-hormone-receptor-ii-amhrii-positive-gynecological-cancers/ 2026-01-14T09:26:14+00:00 https://www.icta.fr/case-studies/a-first-in-human-trial-of-monoclonal-antibody-imp-in-patients-with-anti-mullerian-hormone-receptor-ii-amhrii-positive-gynecological-cancers/ 2026-01-14T09:26:13+00:00 https://www.icta.fr/fr/cas-clients/lung-cancer-patients-treated-with-a-new-pd-1-imp-a-longitudinal-prospective-observational-multicentric-study-in-france/ 2026-01-14T09:25:05+00:00 https://www.icta.fr/case-studies/lung-cancer-patients-treated-with-a-new-pd-1-imp-a-longitudinal-prospective-observational-multicentric-study-in-france/ 2026-01-14T09:24:55+00:00 https://www.icta.fr/fr/cas-clients/a-prospective-study-on-an-imp-pet-ct-imaging-in-biochemical-recurrence-of-prostate-cancer/ 2026-01-14T09:23:47+00:00 https://www.icta.fr/case-studies/a-prospective-study-on-an-imp-pet-ct-imaging-in-biochemical-recurrence-of-prostate-cancer/ 2026-01-14T09:23:47+00:00 https://www.icta.fr/fr/cas-clients/pain-relief-and-protection-of-three-self-treated-dermatological-foot-conditions/ 2026-01-14T09:22:57+00:00 https://www.icta.fr/fr/cas-clients/open-non-controlled-parallel-cohorts-multicenter-phase-2a-trial-for-the-evaluation-of-the-antitumor-activity-of-an-imp-single-agent-and-in-combination-with-chemotherapy-in-patients-with-locally-ad/ 2026-01-14T09:22:01+00:00 https://www.icta.fr/case-studies/open-non-controlled-parallel-cohorts-multicenter-phase-2a-trial-for-the-evaluation-of-the-antitumor-activity-of-an-imp-single-agent-and-in-combination-with-chemotherapy-in-patients-with-locally-ad/ 2026-01-14T09:21:40+00:00 https://www.icta.fr/case-studies/derived-cell-atmp-implantation-for-the-treatment-of-fecal-incontinence-a-multicentre-randomized-double-blind-placebo-controlled-parallel-group-dose-finding-clinical-study/ 2026-01-14T09:20:37+00:00 https://www.icta.fr/fr/cas-clients/derived-cell-atmp-implantation-for-the-treatment-of-fecal-incontinence-a-multicentre-randomized-double-blind-placebo-controlled-parallel-group-dose-finding-clinical-study/ 2026-01-14T09:20:24+00:00 https://www.icta.fr/case-studies/a-phase-1-2-open-label-safety-tolerability-and-preliminary-efficacy-study-of-implantation-into-one-eye-of-an-atmp-in-patients-with-retinitis-pigmentosa-due-to-monogenic-mutation/ 2026-01-14T09:19:09+00:00 https://www.icta.fr/fr/cas-clients/a-phase-1-2-open-label-safety-tolerability-and-preliminary-efficacy-study-of-implantation-into-one-eye-of-an-atmp-in-patients-with-retinitis-pigmentosa-due-to-monogenic-mutation/ 2026-01-14T09:19:02+00:00 https://www.icta.fr/case-studies/long-term-safety-evaluation-of-a-medicinal-product-in-inherited-haematological-disorder-in-europe/ 2026-01-14T09:17:28+00:00 https://www.icta.fr/fr/cas-clients/long-term-safety-evaluation-of-a-medicinal-product-in-inherited-haematological-disorder-in-europe/ 2026-01-14T09:17:17+00:00 https://www.icta.fr/case-studies/prevention-treatment-of-a-non-serious-dermatological-condition-on-the-foot/ 2026-01-14T09:16:18+00:00 https://www.icta.fr/fr/cas-clients/prevention-treatment-of-a-non-serious-dermatological-condition-on-the-foot/ 2026-01-14T09:14:51+00:00 https://www.icta.fr/case-studies/pain-relief-and-protection-of-three-self-treated-dermatological-foot-conditionscase-study-template/ 2023-07-05T14:25:17+00:00